Unknown

Dataset Information

0

High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis.

ABSTRACT:

SUBMITTER: Messori A 

PROVIDER: S-EPMC5839620 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis.

Messori Andrea A   Peyvandi Flora F   Trippoli Sabrina S   Palla Roberta R   Rosendaal Frits R FR   Mannucci Pier Mannuccio PM  

Blood transfusion = Trasfusione del sangue 20170515 2

Similar Datasets

Unknown PROTECT VIII Kids: BAY 94-9027 (PEGylated Recombinant Factor VIII) safety and efficacy in previously treated children with severe haemophilia A.
| S-EPMC7317355 | biostudies-literature
Unknown Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study.
| S-EPMC11625208 | biostudies-literature
Unknown Longitudinal Evaluation of Immunological Biomarkers in Previously Untreated/Minimally Treated Patients With Severe and Moderately Severe Haemophilia A During Exposure to Factor VIII: Results From the HEMFIL Study.
| S-EPMC12311890 | biostudies-literature
Unknown Extension Study With rVIII-SingleChain in Previously Untreated Patients (PUPs) With Severe Haemophilia A.
| S-EPMC11957422 | biostudies-literature
Unknown Efficacy and Safety of Recombinant Factor VIII in Previously Untreated and Previously Treated Children with Hemophilia A: A Systematic Review.
| S-EPMC12006257 | biostudies-literature
Unknown Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study.
| S-EPMC8570909 | biostudies-literature
Unknown Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study.
| S-EPMC7776246 | biostudies-literature
Unknown Recombinant factor VIII Fc for the treatment of haemophilia A.
| S-EPMC8252769 | biostudies-literature
Unknown Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study.
| S-EPMC7384031 | biostudies-literature
Unknown Efficacy, safety and bioequivalence of the human-derived B-domain-deleted recombinant factor VIII TQG202 for prophylaxis in severe haemophilia A patients.
| S-EPMC9805152 | biostudies-literature